UCB : Accelerating focus on the patient – 4-traders (press release)

by admin on February 5, 2013

UCB : Accelerating focus on the patient
4-traders (press release)
Cimzia® (certolizumab pegol) in rheumatoid arthritis and Crohn's disease*, Vimpat® (lacosamide) in epilepsy, and Neupro® (rotigotine) in Parkinson's disease and restless legs syndrome, which are major growth drivers worldwide and more particularly

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: